The New England journal of medicine, 2024-02, Vol.390 (9), p.795-805
- Kowdley, Kris V.
- Bowlus, Christopher L.
- Levy, Cynthia
- Akarca, Ulus S.
- Alvares-da-Silva, Mario Reis
- Andreone, Pietro
- Arrese, Marco
- Corpechot, Christophe
- Francque, Sven M.
- Heneghan, Michael A.
- Invernizzi, Pietro
- Jones, David
- Kruger, Frederik C.
- Lawitz, Eric
- Mayo, Marlyn J.
- Shiffman, Mitchell L.
- Swain, Mark G.
- Valera, José Miguel
- Vargas, Victor
- Vierling, John M.
- Villamil, Alejandra
- Addy, Carol
- Dietrich, Julie
- Germain, Jean-Michel
- Mazain, Sarah
- Rafailovic, Dragutin
- Taddé, Bachirou
- Miller, Benjamin
- Shu, Jianfen
- Zein, Claudia O.
- Schattenberg, Jörn M.
2024
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Kowdley, Kris V.
- Bowlus, Christopher L.
- Levy, Cynthia
- Akarca, Ulus S.
- Alvares-da-Silva, Mario Reis
- Andreone, Pietro
- Arrese, Marco
- Corpechot, Christophe
- Francque, Sven M.
- Heneghan, Michael A.
- Invernizzi, Pietro
- Jones, David
- Kruger, Frederik C.
- Lawitz, Eric
- Mayo, Marlyn J.
- Shiffman, Mitchell L.
- Swain, Mark G.
- Valera, José Miguel
- Vargas, Victor
- Vierling, John M.
- Villamil, Alejandra
- Addy, Carol
- Dietrich, Julie
- Germain, Jean-Michel
- Mazain, Sarah
- Rafailovic, Dragutin
- Taddé, Bachirou
- Miller, Benjamin
- Shu, Jianfen
- Zein, Claudia O.
- Schattenberg, Jörn M.
- Titel
- Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
- Ist Teil von
- The New England journal of medicine, 2024-02, Vol.390 (9), p.795-805
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2024
- Quelle
- EZB Free E-Journals
- Beschreibungen/Notizen
- In a trial involving patients with primary biliary cholangitis, treatment with elafibranor, a dual PPAR-α and PPAR-δ agonist, led to greater improvements in biochemical indicators of cholestasis than placebo.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2306185Titel-ID: cdi_proquest_miscellaneous_2889995658
- Format
- –
- Schlagworte
- Acids, Alkaline phosphatase, Allergy, Autoimmune Disease, Bile, Bile ducts, Bilirubin, Biomarkers, Cholangitis, Cholestasis, Cholesterol, Diarrhea, Fibrosis, Gastroenterology, Gastroenterology General, Hepatitis, Hypothesis testing, Immunology, Inflammatory Disease, Lipoproteins, Liver cirrhosis, Liver Disease, Liver diseases, Missing data, Patients, Peroxisome proliferator-activated receptors, Phosphatase, Placebos, Pruritus, Quality of life, Ursodeoxycholic acid